Melatonin and ischemic stroke: Mechanistic roles and action

Advances in Pharmacological Sciences

Volumn 2015, Issue , 2015, Pages

  Andrabi, Syed Suhail ^a   Parvez, Suhel ^a   Tabassum, Heena ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CASPASE; ENDOTHELIN 1; MELATONIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RECEPTOR; TRANSCRIPTION FACTOR NRF2;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGY; BRAIN ISCHEMIA; CELL DEATH; EXCITOTOXICITY; HUMAN; INFLAMMATION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84942342369     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2015/384750     Document Type: Article

References (133)

1. C. D. Mathers, T. Boerma, and D. Ma Fat, "Global and regional causes of death," BritishMedical Bulletin, vol. 92, no. 1, pp. 7-32, 2009.
2. R. W. V. Flynn, R. S. M. MacWalter, and A. S. F. Doney, "The cost of cerebral ischaemia," Neuropharmacology, vol. 55, no. 3, pp. 250-256, 2008.
3. R. S. Pandya, L. Mao, H. Zhou et al., "Central nervous system agents for ischemic stroke: neuroprotection mechanisms," Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 2, pp. 81-97, 2011.
4. Y. Jin, N. Raviv, A. Barnett et al., "The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal model," PLoS ONE, vol. 10, no. 4, Article IDe0124657, 2015.
5. B. Wali, T. Ishrat, S. Won, D. G. Stein, and I. Sayeed, "Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study," Brain, vol. 137, no. 2, pp. 486-502, 2013.
6. A. Canazza, L. Minati, C. Boffano, E. Parati, and S. Binks, "Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cellbased therapies," Frontiers in Neurology, vol. 5, article 19, 2014.
7. R. Jin, X. Zhu, and G. Li, "Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats," Journal of Visualized Experiments, no. 91, Article ID 51956, 2014.
8. K.-A. Hossmann, "The two pathophysiologies of focal brain ischemia: implications for translational stroke research," Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 7, pp. 1310-1316, 2012.
9. W.-D. Heiss, "The ischemic penumbra: how does tissue injury evolve?" Annals of the New York Academy of Sciences, vol. 1268, no. 1, pp. 26-34, 2012.
10. T. M. Woodruff, J. Thundyil, S.-C. Tang, C. G. Sobey, S. M. Taylor, and T. V. Arumugam, "Pathophysiology, treatment, and animal and cellular models of human ischemic stroke," Molecular Neurodegeneration, vol. 6, no. 1, article 11, 2011.
11. A. Purushotham, B. C. V. Campbell, M. Straka et al., "Apparent diffusion coefficient threshold for delineation of ischemic core," International Journal of Stroke, vol. 10, no. 3, pp. 348-353, 2015.
12. M. Fisher and B. Bastan, "Identifying and utilizing the ischemic penumbra," Neurology, vol. 79, no. 13, pp. S79-S85, 2012.
13. M. Fisher and B. Bastan, "Identifying and utilizing the ischemic penumbra," Neurology, vol. 79, no. 13, supplement 1, pp. S79-S85, 2012.
14. H. Li, N. Zhang, H.-Y. Lin et al., "Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice," BMC Neuroscience, vol. 15, article 58, 2014.
15. T. Chiang, R. O. Messing, and W. H. Chou, "Mouse model of middle cerebral artery occlusion," Journal of Visualized Experiments, vol. 13, no. 48, p. 2761, 2011.
16. M. Pompili, P. Venturini, D. A. Lamis et al., "Suicide in stroke survivors: epidemiology and prevention," Drugs and Aging, vol. 32, no. 1, pp. 21-29, 2014.
17. H. Sies, "Oxidative stress: a concept in redox biology and medicine," Redox Biology, vol. 4, pp. 180-183, 2015.
18. B. Halliwell, "Free radicals and antioxidants-quo vadis?" Trends in Pharmacological Sciences, vol. 32, no. 3, pp. 125-130, 2011.
19. M. L. Dallas, J. P. Boyle, C. J.Milligan et al., "Carbon monoxide protects against oxidant-induced apoptosis via inhibition of K2.1," The FASEB Journal, vol. 25, no. 5, pp. 1519-1530, 2011.
20. J. W. Thompson, S. V. Narayanan, and M. A. Perez-Pinzon, "Redox signaling pathways involved in neuronal ischemic preconditioning,"CurrentNeuropharmacology, vol. 10,no. 4, pp. 354-369, 2012.
21. R. M. Adibhatla and J. F. Hatcher, "Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies," Journal of Biochemistry andMolecular Biology, vol. 41, no. 8, pp. 560-567, 2008.
22. H.-M. Gao, H. Zhou, and J.-S. Hong, "NADPH oxidases: novel therapeutic targets for neurodegenerative diseases," Trends in Pharmacological Sciences, vol. 33, no. 6, pp. 295-303, 2012.
23. J. C. Lee and M. H. Won, "Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils," Anatomy and Cell Biology, vol. 47, no. 3, pp. 149-156, 2014.
24. K. Niizuma, H. Yoshioka, H. Chen et al., "Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1802, no. 1, pp. 92-99, 2010.
25. T. H. Sanderson, C. A. Reynolds, R. Kumar, K. Przyklenk, and M. Huttemann, "Molecular mechanisms of ischemiareperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation," Molecular Neurobiology, vol. 47, no. 1, pp. 9-23, 2013.
26. T. W. Lai, S. Zhang, and Y. T. Wang, "Excitotoxicity and stroke: identifying novel targets for neuroprotection," Progress in Neurobiology, vol. 115, pp. 157-188, 2014.
27. A. Lau and M. Tymianski, "Glutamate receptors, neurotoxicity and neurodegeneration," Pflugers Archiv, vol. 460, no. 2, pp. 525-542, 2010.
28. A. M. Dolga, N. Terpolilli, F. Kepura et al., "KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia," Cell Death and Disease, vol. 2, no. 4, article e147, 2011.
29. S. A. Andrabi, H. C. Kang, J.-F.Haince et al., "Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death," Nature Medicine, vol. 17, no. 6, pp. 692-699, 2011.
30. Q. Zhao, S. Wang, Y. Li et al., "The role of the mitochondrial calcium uniporter in cerebral ischemia/reperfusion injury in rats involves regulation of mitochondrial energy metabolism," Molecular Medicine Reports, vol. 7, no. 4, pp. 1073-1080, 2013.
31. L. C. Constantino, C. I. Tasca, and C. R. Boeck, "The role of NMDA receptors in the development of brain resistance through pre-and postconditioning," Aging and Disease, vol. 5, no. 6, pp. 430-441, 2014.
32. M. M. Harraz, S. M. Eacker, X. Wang, T. M. Dawson, and V. L. Dawson, "MicroRNA-223 is neuroprotective by targeting glutamate receptors," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. 18962-18967, 2012.
33. X. Wang, B. E. Figueroa, I. G. Stavrovskaya et al., "Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury," Stroke, vol. 40, no. 5, pp. 1877-1885, 2009.
34. P. Bhattacharya, A. K. Pandey, S. Paul, and R. Patnaik, "Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia," Life Sciences, vol. 100, no. 2, pp. 97-109, 2014.
35. S.-H. Tai, H.-Y. Chen, E.-J. Lee et al., "Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenousMMPinhibitor in mice subjected to transient focal cerebral ischemia," Journal of Pineal Research, vol. 49, no. 4, pp. 332-341, 2010.
36. X. Hu, P. Li, Y. Guo et al., "Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia," Stroke, vol. 43, no. 11, pp. 3063-3070, 2012.
37. W.-S. Juan, S.-Y. Huang, C.-C. Chang et al., "Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period," Journal of Pineal Research, vol. 56, no. 2, pp. 213-223, 2014.
38. H. Li, Y.Wang, D. Feng et al., "Alterations in the time course of expression of the Nox family in the brain in a rat experimental cerebral ischemia and reperfusion model: effects of melatonin," Journal of Pineal Research, vol. 57, no. 1, pp. 110-119, 2014.
39. Y.-X. Han, S.-H. Zhang, X.-M.Wang, and J.-B.Wu, "Inhibition of mitochondria responsible for the anti-apoptotic effects of melatonin during ischemia-reperfusion," Journal of Zhejiang University Science B, vol. 7, no. 2, pp. 142-147, 2006.
40. E. Kilic, U. Kilic, M. Bacigaluppi et al., "Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice," Journal of Pineal Research, vol. 45, no. 2, pp. 142-148, 2008.
41. J. Song, S. M. Kang,W. T. Lee, K. A. Park, K. M. Lee, and J. E. Lee, "The beneficial effect ofmelatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusioninduced injury," OxidativeMedicine and Cellular Longevity, vol. 2014, Article ID639531, 14 pages, 2014.
42. S. A. Andrabi, I. Sayeed, D. Siemen, G. Wolf, and T. F. W. Horn, "Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for antiapoptotic effects of melatonin," The FASEB Journal, vol. 18, no. 7, pp. 869-871, 2004.
43. C. Thornton and H. Hagberg, "Role of mitochondria in apoptotic and necroptotic cell death in the developing brain," Clinica Chimica Acta, 2015.
44. M. H. Singh, S. M. Brooke, I. Zemlyak, and R. M. Sapolsky, "Evidence for caspase effects on release of cytochrome c and AIF in a model of ischemia in cortical neurons," Neuroscience Letters, vol. 469, no. 2, pp. 179-183, 2010.
45. L.Portt,G.Norman, C. Clapp,M. Greenwood, andM.T.Greenwood, "Anti-apoptosis and cell survival: a review," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1813, no. 1, pp. 238-259, 2011.
46. S. Fulda, A.M. Gorman, O. Hori, andA. Samali, "Cellular stress responses: cell survival and cell death," International Journal of Cell Biology, vol. 2010, Article ID 214074, 23 pages, 2010.
47. E. A. Jonas, G. A. Porter Jr., G. Beutner, N. Mnatsakanyan, and K. N. Alavian, "Cell death disguised: the mitochondrial permeability transition pore as the c-subunit of the F1F ATP synthase," Pharmacological Research, 2015.
48. V. Giorgio, S. S. von Stockum, M. Antoniel et al., "Dimers of mitochondrial ATP synthase form the permeability transition pore," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 15, pp. 5887-5892, 2013.
49. H.Huang, X.Hu, C. O. Eno, G. Zhao, C. Li, and C.White, "An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotesmitochondrialCa2+ uptake," Journal of Biological Chemistry, vol. 288, no. 27, pp. 19870-19881, 2013.
50. J. Karch, J. Q. Kwong, and A. R. Burr, "Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice," Elife, vol. 27, no. 2, Article ID e00772, 2013.
51. S.-Y. Ryu, P. M. Peixoto, O. Teijido, L. M. Dejean, and K. W. Kinnally, "Role of mitochondrial ion channels in cell death," BioFactors, vol. 36, no. 4, pp. 255-263, 2010.
52. Q. Chen, H. Xu, A. Xu et al., "Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria," PLOS ONE, vol. 10, no. 3, Article ID e0118834, 2015.
53. L. M. Dejean, S.-Y. Ryu, S.Martinez-Caballero, O. Teijido, P.M. Peixoto, and K. W. Kinnally, "MAC and Bcl-2 family proteins conspire in a deadly plot," Biochimica et Biophysica Acta-Bioenergetics, vol. 1797, no. 6-7, pp. 1231-1238, 2010.
54. C. Brenner and M. Moulin, "Physiological roles of the permeability transition pore," Circulation Research, vol. 111, no. 9, pp. 1237-1247, 2012.
55. R. Abeti and A. Y. Abramo, "Mitochondrial Ca2+ in neurodegenerative disorders," Pharmacological Research, vol. 6618, no. 15, pp. 91-92, 2015.
56. J. Yuan, "Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke," Apoptosis, vol. 14, no. 4, pp. 469-477, 2009.
57. M. A. Moskowitz, E. H. Lo, and C. Iadecola, "The science of stroke:mechanisms in search of treatments," Neuron, vol. 67,no. 2, pp. 181-198, 2010.
58. N. R. Sims and H. Muyderman, "Mitochondria, oxidative metabolism and cell death in stroke," Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 80-91, 2010.
59. H. Zhang, Y.-W. Zhang, Y. Chen et al., "Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration," Journal of Neuroscience, vol. 32, no. 44, pp. 15565-15576, 2012.
60. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, "Apoptotic mechanisms after cerebral ischemia," Stroke, vol. 40, no. 5, pp. e331-e339, 2009.
61. L. Jie, C. Yuqin, D. Yao, H. Shuai, andW. Yuanyuan, "Occlusion of middle cerebral artery induces apoptosis of cerebellar cortex neural cells via caspase-3 in rats," Turkish Neurosurgery, vol. 21, no. 4, pp. 567-574, 2011.
62. S. Nowsheen and E. S. Yang, "The intersection between DNA damage response and cell death pathways," ExperimentalOncology, vol. 34, no. 3, pp. 243-254, 2012.
63. E. Norberg, S. Orrenius, and B. Zhivotovsky, "Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF)," Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 95-100, 2010.
64. B. M. Polster, "AIF, reactive oxygen species, and neurodegeneration: a complex problem," Neurochemistry International, vol. 62, no. 5, pp. 695-702, 2013.
65. N.Doti, C. Reuther, P. L. Scognamiglio et al., "Inhibition of the AIF/CypA complex protects against intrinsic death pathways induced by oxidative stress," Cell Death and Disease, vol. 16, no. 5, article e993, 2014.
66. S. A. Andrabi, T. M.Dawson, andV. L.Dawson, "Mitochondrial and nuclear cross talk in cell death: parthanatos," Annals of the New York Academy of Sciences, vol. 1147, pp. 233-241, 2008.
67. E. Batnasan, R. Wang, J. Wen et al., "17-Beta estradiol inhibits oxidative stress-induced accumulation of AIF into nucleolus and PARP1-dependent cell death via estrogen receptor alpha," Toxicology Letters, vol. 232, no. 1, pp. 1-9, 2015.
68. K. K. David, S. A. Andrabi, T. M. Dawson, and V. L. Dawson, "Parthanatos, amessenger of death," Frontiers in Bioscience, vol. 14, no. 3, pp. 1116-1128, 2009.
69. Y. Wang, N. S. Kim, X. Li et al., "Calpain activation is not required for AIF translocation in PARP-1-dependent cell death (parthanatos)," Journal of Neurochemistry, vol. 110, no. 2, pp. 687-696, 2009.
70. S.-H. Baek, O.-N. Bae, E.-K. Kim, and S.-W. Yu, "Induction of mitochondrial dysfunction by poly(ADP-ribose) polymer: implication for neuronal cell death,"Molecules and Cells, vol. 36, no. 3, pp. 258-266, 2013.
71. J. Pei, X. You, and Q. Fu, "Inflammation in the pathogenesis of ischemic stroke," Frontiers in Bioscience, vol. 20, no. 4, pp. 772-783, 2015.
72. C. Iadecola and J. Anrather, "The immunology of stroke: from mechanisms to translation," Nature Medicine, vol. 17, no. 7, pp. 796-808, 2011.
73. M. Kawabori and M. A. Yenari, "Inflammatory responses in brain ischemia," Current Medicinal Chemistry, vol. 22, no. 10, pp. 1258-1277, 2015.
74. G. Yilmaz and D. N. Granger, "Leukocyte recruitment and ischemic brain injury," NeuroMolecular Medicine, vol. 12, no. 2, pp. 193-204, 2010.
75. A. Chamorro, A.Meisel, A. M. Planas, X. Urra, D. Van de Beek, and R. Veltkamp The immunology of acute stroke Nature Reviews Neurology 8 7 401-410 2012.
76. B. M. Famakin, "The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review," Aging and Disease, vol. 5, no. 5, pp. 307-326, 2014.
77. L. Wu, K. Zhang, G. Hu, H. Yang, C. Xie, and X. Wu, "Inflammatory response and neuronal necrosis in rats with cerebral ischemia," Neural Regeneration Research, vol. 9, no. 19, pp. 1753-1762, 2014.
78. T. Dziedzic, "Systemic inflammation as a therapeutic target in acute ischemic stroke," Expert Review of Neurotherapeutics, vol. 15, no. 5, pp. 523-531, 2015.
79. D. N. Doll, T. L. Barr, and J. W. Simpkins, "Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets," Aging and Disease, vol. 5, no. 5, pp. 294-306, 2014.
80. H.C.Pan,C.N.Yang, Y.W. Hung et al., "Reciprocalmodulation of C/EBP- and C/EBP- by IL-13 in activated microglia prevents neuronal death," European Journal of Immunology, vol. 43, no. 11, pp. 2854-2865, 2013.
81. E. C. Koellhoffer and L.D.McCullough, "Theeffects of estrogen in ischemic stroke," Translational Stroke Research, vol. 4, no. 4, pp. 390-401, 2013.
82. D. A. Schreihofer and Y. Ma, "Estrogen receptors and ischemic neuroprotection: who, what,where, and when?" Brain Research, vol. 1514, pp. 107-122, 2013.
83. I. Sayeed and D. G. Stein, "Progesterone as a neuroprotective factor in traumatic and ischemic brain injury," Progress in Brain Research, vol. 175, pp. 219-237, 2009.
84. H.-M. Zhang and Y. Zhang, "Melatonin: a well-documented antioxidant with conditional pro-oxidant actions," Journal of Pineal Research, vol. 57, no. 2, pp. 131-146, 2014.
85. A. Galano, D. X. Tan, and R. J. Reiter, "Melatonin as a natural ally against oxidative stress: a physicochemical examination," Journal of Pineal Research, vol. 51, no. 1, pp. 1-16, 2011.
86. J. J. Garć?a, L. Ĺopez-Pingarŕon, P. Almeida-Souza et al., "Protective effects ofmelatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review," Journal of Pineal Research, vol. 56, no. 3, pp. 225-237, 2014.
87. E. Miller, A. Morel, L. Saso, and J. Saluk, "Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders," Current Topics inMedicinal Chemistry, vol. 15, no. 2, pp. 163-169, 2015.
88. A. Chattoraj, T. Liu, L. S. Zhang, Z. Huang, and J. Borjigin, "Melatonin formation in mammals: in vivo perspectives," Reviews in Endocrine andMetabolic Disorders, vol. 10, no. 4, pp. 237-243, 2009.
89. J. B. Zawilska, D. J. Skene, and J. Arendt, "Physiology and pharmacology of melatonin in relation to biological rhythms," Pharmacological Reports, vol. 61, no. 3, pp. 383-410, 2009.
90. P. M. Iuvone, G. Tosini, N. Pozdeyev, R. Haque, D. C. Klein, and S. S. Chaurasia, "Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina," Progress in Retinal and Eye Research, vol. 24, no. 4, pp. 433-456, 2005.
91. I. Semak, E. Korik, M. Antonova, J.Wortsman, and A. Slominski, "Metabolismof melatonin by cytochrome P450s in rat liver mitochondria and microsomes," Journal of Pineal Research, vol. 45, no. 4, pp. 515-523, 2008.
92. B. Claustrat and J. Leston, "Melatonin: physiological effects in humans," Neurochirurgie, vol. 61, no. 2-3, pp. 77-84, 2015.
93. R. Hardeland and B. Poeggeler, "Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system," Central Nervous System Agents in Medicinal Chemistry, vol. 12, no. 3, pp. 189-216, 2012.
94. B. P. Lucke-Wold, K. E. Smith, L. Nguyen et al., "Sleep disruption and the sequelae associated with traumatic brain injury," Neuroscience and Biobehavioral Reviews, vol. 55, pp. 68-77, 2015.
95. B. V. Jardim, L. C. Ferreira, T. F. Borin et al., "Evaluation of the anti-angiogenic action of melatonin in breast cancer," BMC Proceedings, vol. 7, supplement 2, article P11, 2003.
96. A. Korkmaz, T. Topal, D.-X. Tan, and R. J. Reiter, "Role of melatonin in metabolic regulation," Reviews in Endocrine and Metabolic Disorders, vol. 10, no. 4, pp. 261-270, 2009.
97. B. Lacoste, D. Angeloni, S. Dominguez-Lopez et al., "Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain," Journal of Pineal Research, vol. 58, no. 4, pp. 397-417, 2015.
98. E. R. V. Rios, E. T. Venncio, N. F. M. Rocha et al., "Melatonin: pharmacological aspects and clinical trends," International Journal of Neuroscience, vol. 120, no. 9, pp. 583-590, 2010.
99. Y.-H.Wu, J. Ursinus, J.-N. Zhou et al., "Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression," Journal of Affective Disorders, vol. 148, no. 2-3, pp. 357-367, 2013.
100. B. M. Escribano, A. Coĺ?n-Gonźalez, A. Santamaŕ?a, and I. Tunez, "The role of melatonin in multiple sclerosis, Huntingtons disease and cerebral ischemia," CNS and Neurological Disorders-Drug Targets, vol. 13, no. 6, pp. 1096-1119, 2014.
101. G. Sarlak, A. Jenwitheesuk, B. Chetsawang, and P. Govitrapong, "Effects of melatonin on nervous system aging: neurogenesis and neurodegeneration," Journal of Pharmacological Sciences, vol. 123, no. 1, pp. 9-24, 2013.
102. Y. Yang, S. Jiang, Y. Dong et al., "Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice," Journal of Pineal Research, vol. 58, no. 1, pp. 61-70, 2015.
103. A. Corrales, R. Vidal, S. Garć?a et al., "Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome," Journal of Pineal Research, vol. 56, no. 1, pp. 51-61, 2014.
104. V. H. Ozacmak, F. Barut, and H. S. Ozacmak, "Melatonin provides neuroprotection by reducing oxidative stress and HSP70 expression during chronic cerebral hypoperfusion in ovariectomized rats," Journal of Pineal Research, vol. 47, no. 2, pp. 156-163, 2009.
105. S. R. Pandi-Perumal, A. S. Bahammam, G. M. Brown et al., "Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes," Neurotoxicity Research, vol. 23, no. 3, pp. 267-300, 2013.
106. X. Wang, "The antiapoptotic activity of melatonin in neurodegenerative diseases," CNSNeuroscience andTherapeutics, vol. 15, no. 4, pp. 345-357, 2009.
107. C.-M. Chern, J.-F. Liao, Y.-H.Wang, and Y.-C. Shen, "Melatonin ameliorates neural function by promoting endogenous neurogenesis through theMT2melatonin receptor in ischemic-stroke mice,"FreeRadical BiologyandMedicine, vol. 52,no. 9, pp. 1634-1647, 2012.
108. V. K. Rao, E. A. Carlson, and S. S. Yan, "Mitochondrial permeability transition pore is a potential drug target for neurodegeneration," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1267-1272, 2014.
109. N. R. Sims and H. Muyderman, "Mitochondria, oxidative metabolism and cell death in stroke," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1802, no. 1, pp. 80-91, 2010.
110. M. K. E. Schafer, A. Pfeiffer, M. Jaeckel, A. Pouya, A. M. Dolga, and A. Methner, "Regulators of mitochondrial Ca2+ homeostasis in cerebral ischemia," Cell and Tissue Research, vol. 357, no. 2, pp. 395-405, 2014.
111. G. Yu, F.Wu, and E.-S.Wang, "BQ-869, a novelNMDAreceptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke," International Journal of Clinical and Experimental Pathology, vol. 8, no. 2, pp. 1213-1225, 2015.
112. X. Wang, "The antiapoptotic activity of melatonin in neurodegenerative diseases," CNS Neuroscience and Therapeutics, vol. 15, no. 4, pp. 345-357, 2009.
113. Y. Gouriou, P. Bijlenga, and N. Demaurex, "Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells," The Journal of Biological Chemistry, vol. 288, no. 18, pp. 12459-12468, 2013.
114. P.-O. Koh, "Melatonin regulates the calcium-buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury," Journal of Pineal Research, vol. 53, no. 4, pp. 358-365, 2012.
115. P. Bhattacharya, A. K. Pandey, S. Paul, and R. Patnaik, "Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia," Life Sciences, vol. 100, no. 2, pp. 97-109, 2014.
116. H. Alluri, C. A. Shaji, M. L. Davis, and B.Tharakan, "Oxygenglucose deprivation and reoxygenation as an in vitro ischemiareperfusion injury model for studying blood-brain barrier dysfunction," Journal of Visualized Experiments, no. 99, Article ID e52699, 2015.
117. E. Esposito and S. Cuzzocrea, "Antiinflammatory activity of melatonin in central nervous system," Current Neuropharmacology, vol. 8, no. 3, pp. 228-242, 2010.
118. W. Balduini, S. Carloni, S. Perrone et al., "The use of melatonin in hypoxic-ischemic brain damage: an experimental study," Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 1, pp. 119-124, 2012.
119. K. Liang, Y. Ye, Y.Wang, J. Zhang, and C. Li, "Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway," Journal of the Neurological Sciences, vol. 344, no. 1-2, pp. 100-104, 2014.
120. Z. Pei and R. T. Cheung, "Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/reperfusion injury in a rat middle cerebral artery occlusion stroke model," Journal of Pineal Research, vol. 37, no. 2, pp. 85-91, 2004.
121. Y. Feng, S. Lu, J. Wang, P. Kumar, L. Zhang, and A. J. Bhatt, "Dexamethasone-induced neuroprotection in hypoxicischemic brain injury in newborn rats is partly mediated viaAkt activation," Brain Research, vol. 1589, pp. 68-77, 2014.
122. A. Hafeez, O. Elmadhoun, C. Peng et al., "Reduced apoptosis by ethanol and its association with PKC- and Akt signaling in ischemic stroke," Aging and Disease, vol. 5, no. 6, pp. 366-372, 2014.
123. Y. Zheng, J. Hou, J. Liu et al., "Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats," Journal of Pharmacological Sciences, vol. 124, no. 3, pp. 354-364, 2014.
124. L. Zhao, X. Liu, J. Liang et al., "Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury viamitochondria translocation of Bcl-xL in mice," Brain Research, vol. 1503, pp. 78-88, 2013.
125. P.-O. Koh, "Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/Bad signaling cascade," Journal of Veterinary Medical Science, vol. 70, no. 11, pp. 1219-1223, 2008.
126. F. Luchetti, B. Canonico, M. Betti et al., "Melatonin signaling and cell protection function," The FASEB Journal, vol. 24, no. 10, pp. 3603-3624, 2010.
127. U. Kilic, E. Kilic, R. J. Reiter, C. L. Bassetti, and D.M.Hermann, "Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice," Journal of Pineal Research, vol. 38, no. 1, pp. 67-71, 2005.
128. P.-O. Koh, "Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway," Neuroscience Letters, vol. 444, no. 1, pp. 74-78, 2008.
129. E. Kilic, U.Kilic,R. J.Reiter, C. L. Bassetti, andD. M. Hermann, "Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1," Journal of Pineal Research, vol. 37, no. 4, pp. 247-251, 2004.
130. E. Parada, I. Buendia, R. Léon et al., "Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression," Journal of Pineal Research, vol. 56, no. 2, pp. 204-212, 2014.
131. J. Vanecek, "Cellular mechanisms of melatonin action," Physiological Reviews, vol. 78, no. 3, pp. 687-721, 1998.
132. C. H. Lee, K.-Y. Yoo, J. H. Choi et al., "Melatonins protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor," Journal of Neuroscience Research, vol. 88, no. 12, pp. 2630-2640, 2010.
133. U. Kilic, B. Yilmaz, M. Ugur et al., "Evidence that membranebound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia," Journal of Pineal Research, vol. 52, no. 2, pp. 228-235, 2012.